Stocks Health care CNMD
NYSE · Health careCONMED Corp (CNMD)
CONMED Corp reported revenue of $1.4B in fiscal 2025, up 5.2% from a year earlier. Net income was $47.1M, a net margin of 3.4%. Operating cash flow minus capital spending left $150.9M of free cash flow in fiscal 2025. At June 30, 2026 it held $37.3M in cash against $834.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 29, 2026.
What CONMED Corp does
CONMED Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NYSE under the ticker CNMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.4B | $47.1M | $1.51 | $150.9M |
| 2024 | $1.3B | $132.4M | $4.25 | $153.9M |
| 2023 | $1.2B | $64.5M | $2.04 | $106.3M |
| 2022 | $1B | -$80.6M | -$2.68 | $11.6M |
| 2021 | $1B | $62.5M | $1.94 | $96.9M |
| 2020 | $862.5M | $9.5M | $0.32 | $51.5M |
Where CNMD ranks in Health care
Dividends
CONMED Corp declared $0.60 per share in fiscal 2025. At the current price that is a yield of 1.32%. It paid out $24.7M in cash dividends, 53% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $0.60 | $24.7M | 53% |
| 2024 | $0.80 | $24.7M | 19% |
| 2023 | $0.80 | $24.5M | 38% |
| 2022 | $0.80 | $24M | n/a |
| 2021 | $0.80 | $23.3M | 37% |
| 2020 | $0.80 | $22.8M | 240% |
Latest SEC filings
What CONMED Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- July 29, 2026Quarterly report 10-Q · period to June 30, 2026
- July 29, 2026
- June 17, 2026
- June 16, 2026
- June 4, 2026
- June 1, 2026
- May 28, 2026
- May 20, 2026
- April 30, 2026Quarterly report 10-Q · period to March 31, 2026
- April 29, 2026Passive stake (5% or more) SCHEDULE 13G
What is CNMD worth? A DCF from its reported cash flow
Insider trades
What the people running CONMED Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 8, 2026 | Kelderman KimDirector | Exercised options | 500 | - |
Questions about CNMD
What does CONMED Corp do?
CONMED Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NYSE under the ticker CNMD.
Is CONMED Corp profitable?
Yes. In fiscal 2025 it reported net income of $47.1M on revenue of $1.4B, a net margin of 3.4%.
How much revenue does CONMED Corp make?
In fiscal 2025 CONMED Corp reported revenue of $1.4B. That is 5.2% more than a year earlier.
When did CONMED Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 29, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 10, 2026.
Similar companies
Compare CNMD with
Follow CNMD
Get an email when CONMED Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow CNMD: get an email when it filesWhere the numbers come from
Financial figures are the values CONMED Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.